Algorithmic Biologics develops a software platform that enhances molecular testing workflows through advanced computational applications, including compression algorithms for next-generation sequencing. This technology significantly reduces library preparation costs by over 60%, making molecular diagnostics more accessible and efficient for healthcare providers.
Funding
$2.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
BIFounders
Product
Problem
Traditional molecular testing workflows can be expensive and time-consuming, particularly in library preparation for next-generation sequencing (NGS), which limits accessibility and efficiency for healthcare providers. High costs and complex procedures create barriers to widespread adoption of molecular diagnostics and discovery.
Solution
Algorithmic Biologics offers a software platform that enhances molecular testing by applying advanced computational methods, including compression algorithms for NGS. Their technology reduces library preparation costs by over 60% while maintaining high concordance. The platform integrates with existing molecular testing workflows, enabling computing applications that improve the accuracy, affordability, and accessibility of molecular diagnostics. By using AI and decades of research in molecular computing and reaction networks, Algorithmic Biologics aims to democratize access to NGS and other molecular tests.
Target Audience
The primary customers are healthcare providers, genomics research labs, and clinical partners seeking to enhance molecular testing workflows, reduce costs, and improve the accessibility of molecular diagnostics.
Features
- Compression algorithms for NGS that reduce library preparation costs by >60%
- AI-powered platform that wraps around standard molecular testing workflows
- Technology agnostic to the underlying molecular test, integrating with existing infrastructure
- Single round, quantitative pooling algorithm with RT-qPCR for affordable and frequent testing
- High concordance in validation studies performed with leading genomics research labs
- DCGI approved and CE mark for IVD